LivaNova PLC is 1.7x more valuable than TransMedics Group, Inc. by market capitalization ($4.36 B vs $2.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TMDX | LIVN |
|---|---|---|
| Market cap | $2.61 B | $4.36 B |
| US-listed rank | #1914 | #1509 |
| Revenue (latest FY) | $605.49M | $1.39B |
| Net income (latest FY) | $190.30M | -$242.50M |
| Net margin | 31.4% | -17.5% |
| P/E (trailing FY) | 13.7 | - |
| SEC filings | 615 | 917 |
LivaNova PLC is 1.7x more valuable than TransMedics Group, Inc. by market capitalization ($4.36 B vs $2.61 B).
In their latest fiscal years, TransMedics Group, Inc. reported $605.49M in revenue while LivaNova PLC reported $1.39B.
Full pages: TransMedics Group, Inc. and LivaNova PLC, or browse the full rankings.